2016年9月28日下午，87978797威尼斯老品牌院长王明伟研究员、院长助理李聪教授、药剂学教研室主任蒋晨教授、陆伟教授、钱隽副教授和孙涛青年副研究员在科研楼晶晖厅会晤了英国葛兰素史克（上海）医药研发有限公司血脑屏障生物学总监张万东博士、生物标志物总监董菁博士、药物安全评价总监王英博士、药物代谢动力学高级研究员刘厚甫博士、动物病理学副总监刘爱莲博士和生物成像高级研究员巩晓明博士，就药学院同该公司在放射药学与脑靶向递药等领域开展合作研究进行了磋商。会后，李聪教授和蒋晨教授陪同来宾们参观了药学院的相关实验设施。
Professor Ming-Wei Wang meets executives of GlaxoSmithKline (Shanghai)
In the afternoon of September 28, 2016, Drs. Ming-Wei Wang (Dean), Cong Li (Assistant Dean), Chen Jiang (Chairman of Pharmaceutics Department), Wei Lu (Professor), Jun Qian (Associate Professor) and Tao Sun (Associate Professor) from School of Pharmacy, Fudan University met with Drs. Wandong Zhang (Director, Blood-Brian Barrier Biology), Kelly C. Dong (Director, Bioanalysis), Ying Wang (Director, Safety Assessment), Houfu Liu (Senior Scientist, Drug Metabolism and Disposition), Ailian Liu (Associate Director, Animal Pathology) and Xiaoming Gong (Senior Scientist, Bioimaging) from GlaxoSmithKline (GSK, U.K.) Shanghai R&D in the Jinghui Hall of the research building. This meeting was arranged to discuss potential collaborative projects related to radiopharmaceuticals and brain-targeting drug delivery. The honorable guests from GSK toured the research facility of the school accompanied by Drs. Cong Li and Chen Jiang after the discussion.
供稿：孙涛
